The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com:
- Adrenal to Brain Transplantation
- Advance Care Planning
- Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover
- Fecal Calprotectin Testing
- Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disorders
- Immune Cell Function Assay
- Intracellular Micronutrient Analysis
- Medical Necessity
- Minimally Invasive Coronary Artery Bypass Graft Surgery
- Nutrient-Nutritional Panel Testing
- Ocriplasmin for Symptomatic Vitreomacular Adhesions
- Phototherapeutic Keratectomy (PTK)
- Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia
- Radiofrequency Coblation Tenotomy for Musculoskeletal Conditions
- Recombinant and Autologous Platelet-Derived Growth Factors for Wound Healing and Other Non-Orthopedic Conditions
- Rhinomanometry and Acoustic/Optical Rhinometry
- Signal-Averaged Electrocardiography (SAECG)
- Temporarily Implanted Nitinol Device (iTind) for Benign Prostatic Hyperplasia
- Thermography
- Urinary Biomarkers for Cancer Screening, Diagnosis and Surveillance.
We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the “Draft Medical Policies” drop-down.